Wallington Asset Management, LLC Eli Lilly & CO Transaction History

Wallington Asset Management, LLC

$654 Million
Q2 2024

A detailed history of Wallington Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Wallington Asset Management, LLC holds 3,962 shares of LLY stock, worth $3.58 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

3,962

Previous 3,992 0.75%

Holding current value

$3.58 Million

Previous $3.11 Million 15.49%

% of portfolio

0.55%

Previous 0.49%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$724.87 - $909.04 $21,746 - $27,271	-30 Reduced 0.75%	3,962 $3.59 Million
Q1 2024 Apr 19, 2024	SELL	$592.2 - $792.28 $47,376 - $63,382	-80 Reduced 1.96%	3,992 $3.11 Million
Q4 2023 Jan 25, 2024	SELL	$525.19 - $619.13 $371,309 - $437,724	-707 Reduced 14.79%	4,072 $2.37 Million
Q3 2023 Oct 30, 2023	BUY	$434.7 - $599.3 $13,041 - $17,979	30 Added 0.63%	4,779 $2.57 Million
Q2 2023 Jul 19, 2023	SELL	$350.74 - $468.98 $139,945 - $187,123	-399 Reduced 7.75%	4,749 $2.23 Million
Q1 2023 Apr 14, 2023	BUY	$310.63 - $364.82 $16,774 - $19,700	54 Added 1.06%	5,148 $1.77 Million
Q4 2022 Jan 25, 2023	SELL	$321.55 - $374.67 $113,828 - $132,633	-354 Reduced 6.5%	5,094 $1.86 Million
Q2 2022 Jul 13, 2022	BUY	$278.73 - $327.27 $81,667 - $95,890	293 Added 5.68%	5,448 $2.21 Million
Q1 2022 Apr 21, 2022	SELL	$234.69 - $291.66 $42,478 - $52,790	-181 Reduced 3.39%	5,155 $1.48 Million
Q4 2021 Jan 25, 2022	BUY	$224.85 - $279.04 $33,727 - $41,856	150 Added 2.89%	5,336 $1.47 Million
Q3 2021 Oct 20, 2021	SELL	$221.6 - $272.71 $18,836 - $23,180	-85 Reduced 1.61%	5,186 $1.2 Million
Q2 2021 Jul 16, 2021	BUY	$180.55 - $233.54 $22,027 - $28,491	122 Added 2.37%	5,271 $1.21 Million
Q1 2021 Apr 16, 2021	BUY	$164.32 - $212.72 $18,239 - $23,611	111 Added 2.2%	5,149 $1.11 Million
Q4 2020 Jan 12, 2021	BUY	$130.46 - $172.63 $54,401 - $71,986	417 Added 9.02%	5,038 $850,000
Q3 2020 Oct 16, 2020	BUY	$146.22 - $169.13 $21,933 - $25,369	150 Added 3.35%	4,621 $684,000
Q2 2020 Jul 17, 2020	SELL	$136.42 - $164.18 $28,648 - $34,477	-210 Reduced 4.49%	4,471 $759,000
Q1 2020 Apr 15, 2020	SELL	$119.05 - $147.35 $27,857 - $34,479	-234 Reduced 4.76%	4,681 $649,000
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $2,883 - $3,136	27 Added 0.55%	4,915 $550,000
Q2 2018 Aug 03, 2018	SELL	$75.7 - $86.88 $30,280 - $34,752	-400 Reduced 7.56%	4,888 $417,000
Q1 2018 May 08, 2018	SELL	$74.21 - $87.6 $22,262 - $26,280	-300 Reduced 5.37%	5,288 $410,000
Q4 2017 Feb 06, 2018	SELL	$81.94 - $87.89 $13,602 - $14,589	-166 Reduced 2.88%	5,588 $472,000
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $443,460 - $492,197	5,754	5,754 $492,000

Others Institutions Holding LLY

# of Institutions

3,865

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $858B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wallington Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wallington Asset Management, LLC with notifications on news.

Account

Wallington Asset Management, LLC Eli Lilly & CO Transaction History